Boule Diagnostics
5.40 SEK
-8.78 %
Less than 1K followers
BOUL
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-8.78 %
-15.63 %
-11.48 %
-33.33 %
-39.87 %
-38.36 %
-58.14 %
-85.16 %
-41.34 %
Boule Diagnostics operates in the medical technology industry and focuses on the development and manufacture of diagnostic instruments for hematology. The company's products are aimed at healthcare institutions and laboratories. The business is global with a main presence in Europe, North America and Asia. Boule Diagnostics was founded in 1956 and is headquartered in Spånga, Sweden.
Read moreMarket cap
209.7M SEK
Turnover
430.39K SEK
Revenue
558.5M
EBIT %
-46.09 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
11/2
2026
Annual report '25
28/4
2026
Interim report Q1'26
13/5
2026
General meeting '26
All
Press releases
3rd party
ShowingAll content types
Boule Diagnostics Announces CEO Transition as Organization Prepares for Next Chapter
Boule Diagnostics – Valberedning inför årsstämman 2026
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools